Tilmann Steinmetz

Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen inKRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study

Beate Schultheis, Dirk Reuter, M. Ebert et al. · Annals of Oncology · 2017 · 121 citations · Full text

Monoclonal Antibody Nimotuzumab, Pancreatic Cancer, Gastrointestinal Oncology +8

Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial

Stefan Boeck, K. Weigang-Köhler, Martin Fuchs et al. · Annals of Oncology · 2007 · 68 citations · Full text

Surgical Oncology, Pancreatic Cancer, Gemcitabine Failure +8

Toxoplasma gondii-induced foetal resorption in mice involves interferon-γ-induced apoptosis and spiral artery dilation at the maternofoetal interface

Alexandre Senegas, Odile Villard, A. Neuville et al. · International Journal for Parasitology · 2008 · 61 citations

Inflammation, Spiral Artery Dilation, Immunology +5

Prospective, Double-Blind, Placebo-Controlled, Multicenter, Randomized Phase III Study with Orally Administered Budesonide for Prevention of Irinotecan (CPT-11)-Induced Diarrhea in Patients with Advanced Colorectal Cancer

Meinolf Karthaus, Harald Balló, W. Abenhardt et al. · Oncology · 2005 · 48 citations

[Efficacy and tolerability of ferric carboxymaltose in geriatric patients with anemia. Data from three non-interventional studies].

Gabriele Röhrig, Tilmann Steinmetz, Jürgen M. Stein et al. · PubMed · 2014 · 16 citations